Haemonetics Corporation
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
16
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 16 to 30, 2026 · next Nov 16
- 2 fees due Feb 4 to 28, 2027 · next Feb 4
- 1 fee due Apr 30, 2027The maintenance fee for System and Method For Measuring Pressure of Fluid Flow (US 11,802,802) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 4 fees due Jun 5 to 19, 2027 · next Jun 5
- 1 fee due Jul 9, 2027The maintenance fee for Cap Removal Device and Thrombelastography Device Having Same (US 11,866,311) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 3 fees due Aug 2 to 20, 2027 · next Aug 2
- 3 fees due Oct 5 to 23, 2027 · next Oct 5
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,775,209 | Apparatus and method for administration of mother's milk In force · From the USPTO record | In force | From the USPTO record | |
| US 8,647,289 | System and method for optimized apheresis draw and return In force · From the USPTO record | In force | From the USPTO record | |
| US 8,808,217 | System and method for plasma reduced platelet collection In force · From the USPTO record | In force | From the USPTO record | |
| US 9,095,665 | Three-line apheresis system and method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,364,600 | System and method for optimized apheresis draw and return In force · From the USPTO record | In force | From the USPTO record | |
| US 9,248,227 | System and method for the re-anticoagulation of platelet rich plasma In force · From the USPTO record | In force | From the USPTO record | |
| US 7,879,615 | Hemostasis analyzer and method In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 9,789,243 | System and method for the re-anticoagulation of platelet rich plasma In force · From the USPTO record | In force | From the USPTO record | |
| US 8,628,489 | Three-line apheresis system and method In force · From the USPTO record | In force | From the USPTO record | |
| US 8,702,637 | System and method for optimized apheresis draw and return In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 82: 7 patents in force now held by others · 33 lapsed for an unpaid fee · 147 ended at full term · 2 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
11 pending · 2 abandoned · 5 no status recorded